Literature DB >> 18394456

Significance of plasma levels of N-terminal Pro-B-type natriuretic peptide on left ventricular remodeling in non-obstructive hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene.

Jarkko Magga1, Petri Sipola, Olli Vuolteenaho, Juha Risteli, Pertti Jääskeläinen, Keijo Peuhkurinen, Johanna Kuusisto.   

Abstract

Hypertrophic cardiomyopathy (HC) is an inherited heart disease characterized by left ventricular (LV) remodeling. The present study was conducted to investigate the association of N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) levels with LV remodeling on magnetic resonance imaging and procollagen formation in 17 healthy controls and 24 patients with nonobstructive HC attributable to an identical Asp175Asn (aspartic acid to asparagine at codon 175) mutation in the alpha-tropomyosin gene. None of the patients had history of decompensated heart failure, and all patients had normal LV ejection fraction. Patients with HC had higher NT-pro-BNP levels compared with controls (median 60 pmol/L, range <40 to 359, vs <40 pmol/L; p <0.001), but 9 patients with HC had normal NT-pro-BNP levels (<40 pmol/L). In patients with HC, levels of NT-pro-BNP were correlated significantly with LV end-systolic volume index (r = 0.50, p <0.05), LV mass index (r = 0.47, p <0.05), proportion of hypokinetic segments (r = 0.50, p <0.05), and levels of serum aminoterminal propeptide of type III procollagen (r = 0.52, p <0.01). When patients with HC were divided into 3 groups on the basis of their NT-pro-BNP levels, there were statistically significant linear associations of LV end-systolic volume (test for linearity p = 0.034), LV mass index (p = 0.009), proportion of hypokinetic segments (p = 0.016), and levels of serum aminoterminal propeptide of type III procollagen (p = 0.020) with NT-pro-BNP levels over the 3 groups, suggesting a tight relation between LV remodeling and levels of NT-pro-BNP. In conclusion, in patients with nonobstructive HC attributable to an Asp175Asn mutation in the alpha-tropomyosin gene, elevated NT-pro-BNP levels are associated with incipient LV remodeling, suggesting that NT-pro-BNP could be used to diagnose insidious unfavorable LV remodeling in HC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18394456     DOI: 10.1016/j.amjcard.2007.11.071

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Degree and distribution of left ventricular hypertrophy as a determining factor for elevated natriuretic peptide levels in patients with hypertrophic cardiomyopathy: insights from cardiac magnetic resonance imaging.

Authors:  Jeong Rang Park; Jin-Oh Choi; Hye Jin Han; Sung-A Chang; Sung-Ji Park; Sang-Chol Lee; Yeon Hyeon Choe; Seung Woo Park; Jae K Oh
Journal:  Int J Cardiovasc Imaging       Date:  2011-04-24       Impact factor: 2.357

2.  Hypertrophic cardiomyopathy family with double-heterozygous mutations; does disease severity suggest doubleheterozygosity?

Authors:  I A W van Rijsingen; J F Hermans-van Ast; Y H J M Arens; S M Schalla; C E M de Die-Smulders; A van den Wijngaard; Y M Pinto
Journal:  Neth Heart J       Date:  2009-12       Impact factor: 2.380

3.  Vascular Endothelial Growth Factor Is Associated with the Morphologic and Functional Parameters in Patients with Hypertrophic Cardiomyopathy.

Authors:  Radek Pudil; Martina Vasatova; Alena Fucikova; Helena Rehulkova; Pavel Rehulka; Vladimir Palicka; Jiri Stulik
Journal:  Biomed Res Int       Date:  2015-12-30       Impact factor: 3.411

4.  A novel homozygous missense SLC25A20 mutation in three CACT-deficient patients: clinical and autopsy data.

Authors:  Yasutsugu Chinen; Kumiko Yanagi; Sadao Nakamura; Noriko Nakayama; Motoko Kamiya; Mami Nakayashiro; Tadashi Kaname; Kenji Naritomi; Koichi Nakanishi
Journal:  Hum Genome Var       Date:  2020-04-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.